Nasal spray flu vaccine trial aims to boost Kids' immunity
NCT ID NCT07545564
First seen Apr 28, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tests a nasal spray flu vaccine in 200 people aged 3 to 17. Researchers will measure antibody levels in the nose to see how well the vaccine works. The goal is to understand the immune response and how long protection lasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Neimenggu CDC
Hohhot, Inner Mongolia, China
Conditions
Explore the condition pages connected to this study.